A Look At Medibank Private’s Valuation As Earnings Soften But The Interim Dividend Rises

Simply Wall St.

Feb 26

AdvertisementWhy Medibank’s latest dividend move matters Medibank Private (ASX:MPL) just reported softer half year earnings, with net income and earnings per share below the prior period, yet the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2614401884"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2614401884\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2614401884?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/7212000-choice2-main-header/1585186560665","is_english":true,"pubTime":"2026-02-26 12:53","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614401884","market":"sg","top_or_hot":-1,"title":"A Look At Medibank Private’s Valuation As Earnings Soften But The Interim Dividend Rises","media":"Simply Wall St.","content":"<div>\n<p>AdvertisementWhy Medibank’s latest dividend move matters Medibank Private (ASX:MPL) just reported softer half year earnings, with net income and earnings per share below the prior period, yet the ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/insurance/asx-mpl/medibank-private-shares/news/a-look-at-medibank-privates-valuation-as-earnings-soften-but\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>A Look At Medibank Private’s Valuation As Earnings Soften But The Interim Dividend Rises</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nA Look At Medibank Private’s Valuation As Earnings Soften But The Interim Dividend Rises\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-26 12:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/au/insurance/asx-mpl/medibank-private-shares/news/a-look-at-medibank-privates-valuation-as-earnings-soften-but><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>AdvertisementWhy Medibank’s latest dividend move matters Medibank Private (ASX:MPL) just reported softer half year earnings, with net income and earnings per share below the prior period, yet the ...</p>\n\n<a href=\"https://simplywall.st/stocks/au/insurance/asx-mpl/medibank-private-shares/news/a-look-at-medibank-privates-valuation-as-earnings-soften-but\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MPL.AU","symbol_name":"MEDIBANK PRIVATE LTD","start_time":0,"source_url":"https://simplywall.st/stocks/au/insurance/asx-mpl/medibank-private-shares/news/a-look-at-medibank-privates-valuation-as-earnings-soften-but","article_id":"2614401884","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/7212000-choice2-main-header/1585186560665"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/insurance/asx-mpl/medibank-private-shares/news/a-look-at-medibank-privates-valuation-as-earnings-soften-but","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614401884","pubTimestamp":1772081593,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Why Medibank’s latest dividend move matters\nMedibank Private (ASX:MPL) just reported softer half year earnings, with net income and earnings per share below the prior period, yet the board lifted the fully franked interim dividend by 6.4%.\nFor investors, that mix of weaker profit and a higher payout raises important questions about how Medibank is balancing capital returns, business investment and its outlook for cash generation over time.\nSee our latest analysis for Medibank Private.\nAt a...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":["earning"],"viewcount":null,"language":"en","relate_stocks":{"MPL.AU":"MEDIBANK PRIVATE LTD"},"translate_title":"随着盈利疲软但中期股息上升，Medibank Private的估值一览","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MPL.AU":1.5},"content_text":"AdvertisementWhy Medibank’s latest dividend move matters Medibank Private (ASX:MPL) just reported softer half year earnings, with net income and earnings per share below the prior period, yet the board lifted the fully franked interim dividend by 6.4%. For investors, that mix of weaker profit and a higher payout raises important questions about how Medibank is balancing capital returns, business investment and its outlook for cash generation over time. See our latest analysis for Medibank Private. At a share price of A$4.43, Medibank’s recent 7 day share price return of a 7.52% decline and year to date share price return of a 7.90% decline contrast with a 1 year total shareholder return of 16.71% and 5 year total shareholder return of 93.77%. This suggests longer term holders have seen gains even as near term momentum has faded around the latest earnings, dividend increase and M&A commentary. If this earnings and dividend update has you thinking about where else capital could work hard in healthcare, it might be worth scanning our 10 healthcare AI stocks as a starting list of ideas. With earnings softer, a higher payout ratio, and plans for more M&A, Medibank’s share price pullback raises a key question for you: is this weakness offering value, or is the market already baking in future growth? Most Popular Narrative: 14.1% Undervalued At A$4.43, the most followed narrative for Medibank Private points to a fair value of A$5.16. This leaves a valuation gap that hinges on execution in health services and digital delivery.  The expansion and scaling of primary care clinics, virtual health, and home care offerings position Medibank to benefit from the shift in consumer preferences toward preventative care and at-home healthcare. This may help differentiate its offering, limit claims inflation, and improve net margins.  Read the complete narrative. Curious what sits behind that A$5.16 figure? The narrative leans on steady membership growth, firmer margins and a future earnings multiple that assumes Medibank continues to earn its place in customers’ health budgets. Result: Fair Value of A$5.16 (UNDERVALUED) Have a read of the narrative in full and understand what's behind the forecasts. However, this narrative still depends on premium affordability not driving policy downgrades, and on competitors or regulators not compressing Medibank’s pricing power and margins. Find out about the key risks to this Medibank Private narrative. Another angle on valuation While the A$5.16 fair value points to Medibank Private looking undervalued on future earnings, its current P/E of 26.3x is higher than both the Australian peer average of 25.2x and a fair ratio of 21x. That gap suggests less margin for error if growth or margins underwhelm. How comfortable are you with paying up for this quality and dividend story? See what the numbers say about this price — find out in our valuation breakdown. ASX:MPL P/E Ratio as at Feb 2026Next Steps After weighing up the softer earnings, richer P/E and dividend lift, it is worth looking straight at the data and forming your own view quickly, including the 2 key rewards and 1 important warning sign that stand out right now. Looking for more investment ideas? If Medibank has sharpened your focus on quality, do not stop here. Use the screener to quickly compare other opportunities that might fit your goals.  Hunt for quality at a reasonable price by reviewing our 6 high quality undervalued stocks that blend earnings strength with sensible valuations. Build a steadier income stream by checking out our 9 dividend fortresses focused on higher yielding payers. Sleep easier at night by scanning 6 resilient stocks with low risk scores that score well on financial resilience and risk checks.   This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}